- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01897766
Special Investigation Of Genotropin Long Follow-Up For Patients With A Small For Gestational Age "Scoped for Japanese"
August 31, 2023 updated by: Pfizer
AN INVESTIGATION INTENDED TO EVALUATE THE LONG-TERM EFFICACY AND SAFETY OF GENOTROPIN IN CHILDREN WITH SGA DWARFISM WITHOUT EPIPHYSEAL CLOSURE. (RETROSPECTIVE STUDY)
The objective of this surveillance is to collect Safety and Effectiveness information for Long term Use of Somatropin for Patients with a Small for Gestational Age (SGA).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
All the patients whom an investigator prescribes Genotropin should be registered consecutively until the number of subjects reaches target number in order to extract patients enrolled into the investigation at random.
Study Type
Observational
Enrollment (Actual)
482
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 years to 20 years (Child, Adult)
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
- A patients who is diagnosed for SGA. (SGA is defined as birth weight and/or length at least 2 standard deviations (SDs) below the mean for gestational age (<or=-2 SD)).
- A patient who is SGA and older than 3 years.
- A patient who has persistent short stature (i.e., remaining at least 2.5 SD below the mean for chronologic age).
Description
Inclusion Criteria:
- A patient who was administered Somatropin (Genotropin).
Exclusion Criteria:
- N/A.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Somatropin
Patients administered Somatropin.
|
0.23 mg to 0.48 mg/kg/week
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants With Adverse Drug Reaction (ADR)
Time Frame: Approximately 11.58 years
|
An adverse drug reaction (ADR) was any untoward medical occurrence attributed to Genotropin in a participant who received Genotropin.
A serious ADR (SADR) was an ADR resulting in any of the following out comes or deemed significant for any other reason: death; life-threatening experience (immediate risk of dying); initial or prolonged inpatient hospitalization; persistent or significant disability/incapacity; congenital anomaly.
Relatedness to Genotropin was assessed by the physician.
|
Approximately 11.58 years
|
|
Change in Height Velocity Standard Deviation (SD) Score for Chronological Age From Baseline At Year 1
Time Frame: Baseline, Year 1
|
Change in height Velocity SD score from baseline was calculated.
Height Velocity SD score = (Height - Standard height for chronological age of gender) / SD.
An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score.
SD score indicates how similar participant was to reference population.
|
Baseline, Year 1
|
|
Change in Height Velocity Standard Deviation (SD) Score for Chronological Age From Baseline at Year 2
Time Frame: Baseline, Year 2
|
Change in height Velocity SD score from baseline was calculated.
Height Velocity SD score = (Height - Standard height for chronological age of gender) / SD.
An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score.
SD score indicates how similar participant was to reference population.
|
Baseline, Year 2
|
|
Change in Height Velocity Standard Deviation (SD) Score for Chronological Age From Baseline at Year 3
Time Frame: Baseline, Year 3
|
Change in height Velocity SD score from baseline was calculated.
Height Velocity SD score = (Height - Standard height for chronological age of gender) / SD.
An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score.
SD score indicates how similar participant was to reference population.
|
Baseline, Year 3
|
|
Change in Height Velocity Standard Deviation (SD) Score for Chronological Age From Baseline at Year 4
Time Frame: Baseline, Year 4
|
Change in height Velocity SD score from baseline was calculated.
Height Velocity SD score = (Height - Standard height for chronological age of gender) / SD.
An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score.
SD score indicates how similar participant was to reference population.
|
Baseline, Year 4
|
|
Change in Height Velocity Standard Deviation (SD) Score for Chronological Age From Baseline at Year 5
Time Frame: Baseline, Year 5
|
Change in height Velocity SD score from baseline was calculated.
Height Velocity SD score = (Height - Standard height for chronological age of gender) / SD.
An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score.
SD score indicates how similar participant was to reference population.
|
Baseline, Year 5
|
|
Change in Height Velocity Standard Deviation (SD) Score for Chronological Age From Baseline at Year 6
Time Frame: Baseline, Year 6
|
Change in height Velocity SD score from baseline was calculated.
Height Velocity SD score = (Height - Standard height for chronological age of gender) / SD.
An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score.
SD score indicates how similar participant was to reference population.
|
Baseline, Year 6
|
|
Change in Height Velocity Standard Deviation (SD) Score for Chronological Age From Baseline at Year 7
Time Frame: Baseline, Year 7
|
Change in height Velocity SD score from baseline was calculated.
Height Velocity SD score = (Height - Standard height for chronological age of gender) / SD.
An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score.
SD score indicates how similar participant was to reference population.
|
Baseline, Year 7
|
|
Change in Height Velocity Standard Deviation (SD) Score for Chronological Age From Baseline at Year 10
Time Frame: Baseline, Year 10
|
Change in height Velocity SD score from baseline was calculated.
Height Velocity SD score = (Height - Standard height for chronological age of gender) / SD.
An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score.
SD score indicates how similar participant was to reference population.
|
Baseline, Year 10
|
|
Change in Height Standard Deviation (SD) Score for Chronological Age From Baseline at Year 1
Time Frame: Baseline, Year 1
|
Change in height SD score from baseline was calculated.
Height SD score = (Height - Standard height for chronological age of gender) / SD.
An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score.
SD score indicates how similar participant was to reference population.
|
Baseline, Year 1
|
|
Change in Height Standard Deviation (SD) Score for Chronological Age From Baseline at Year 2
Time Frame: Baseline, Year 2
|
Change in height SD score from baseline was calculated.
Height SD score = (Height - Standard height for chronological age of gender) / SD.
An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score.
SD score indicates how similar participant was to reference population.
|
Baseline, Year 2
|
|
Change in Height Standard Deviation (SD) Score for Chronological Age From Baseline at Year 3
Time Frame: Baseline, Year 3
|
Change in height SD score from baseline was calculated.
Height SD score = (Height - Standard height for chronological age of gender) / SD.
An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score.
SD score indicates how similar participant was to reference population.
|
Baseline, Year 3
|
|
Change in Height Standard Deviation (SD) Score for Chronological Age From Baseline at Year 4
Time Frame: Baseline, Year 4
|
Change in height SD score from baseline was calculated.
Height SD score = (Height - Standard height for chronological age of gender) / SD.
An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score.
SD score indicates how similar participant was to reference population.
|
Baseline, Year 4
|
|
Change in Height Standard Deviation (SD) Score for Chronological Age From Baseline at Year 5
Time Frame: Baseline, Year 5
|
Change in height SD score from baseline was calculated.
Height SD score = (Height - Standard height for chronological age of gender) / SD.
An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score.
SD score indicates how similar participant was to reference population.
|
Baseline, Year 5
|
|
Change in Height Standard Deviation (SD) Score for Chronological Age From Baseline at Year 6
Time Frame: Baseline, Year 6
|
Change in height SD score from baseline was calculated.
Height SD score = (Height - Standard height for chronological age of gender) / SD.
An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score.
SD score indicates how similar participant was to reference population.
|
Baseline, Year 6
|
|
Change in Height Standard Deviation (SD) Score for Chronological Age From Baseline at Year 7
Time Frame: Baseline, Year 7
|
Change in height SD score from baseline was calculated.
Height SD score = (Height - Standard height for chronological age of gender) / SD.
An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score.
SD score indicates how similar participant was to reference population.
|
Baseline, Year 7
|
|
Change in Height Standard Deviation (SD) Score for Chronological Age From Baseline at Year 9
Time Frame: Baseline, Year 9
|
Change in height SD score from baseline was calculated.
Height SD score = (Height - Standard height for chronological age of gender) / SD.
An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score.
SD score indicates how similar participant was to reference population.
|
Baseline, Year 9
|
|
Change in Height Standard Deviation (SD) Score for Chronological Age From Baseline at Year 10
Time Frame: Baseline, Year 10
|
Change in height SD score from baseline was calculated.
Height SD score = (Height - Standard height for chronological age of gender) / SD.
An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score.
SD score indicates how similar participant was to reference population.
|
Baseline, Year 10
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Height Standard Deviation (SD) Score at Puberty and at Near Final Height in Participants Who Reached Near Final Height
Time Frame: Baseline, At Puberty, At Near Final Height within the span of approximately maximum of 11.58 years
|
Height SD score = (Height - Standard height for chronological age of gender) / SD.
An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score.
SD score indicates how similar participant was to reference population.
Near final height was defined as the height at one of the following conditions: the annual height velocity became less than 2 cm/year after reaching the maximum height in puberty, bone age reached 17 years old and older for male and 15 years old and older for female, or the reason for discontinuation was that subject reached the near final height or had epiphyseal closure.
|
Baseline, At Puberty, At Near Final Height within the span of approximately maximum of 11.58 years
|
|
Change in Height Standard Deviation (SD) Score at Puberty and at Near Final Height in Participants Who Reached Near Final Height From Baseline
Time Frame: Baseline, At Puberty, At Near Final Height within the span of approximately maximum of 11.58 years
|
Change in height SD score from baseline was calculated.
Height SD score = (Height - Standard height for chronological age of gender) / SD.
An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score.
SD score indicates how similar participant was to reference population.
Near final height was defined as the height at one of the following conditions: the annual height velocity became less than 2 cm/year after reaching the maximum height in puberty, bone age reached 17 years old and older for male and 15 years old and older for female, or the reason for discontinuation was that subject reached the near final height or had epiphyseal closure.
|
Baseline, At Puberty, At Near Final Height within the span of approximately maximum of 11.58 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Pfizer CT.gov Call Center, Pfizer
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 5, 2013
Primary Completion (Actual)
February 28, 2017
Study Completion (Actual)
June 7, 2017
Study Registration Dates
First Submitted
July 9, 2013
First Submitted That Met QC Criteria
July 9, 2013
First Posted (Estimated)
July 12, 2013
Study Record Updates
Last Update Posted (Actual)
September 25, 2023
Last Update Submitted That Met QC Criteria
August 31, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- A6281314
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Pfizer will provide access to individual de-identified participant data and related study documents (e.g.
protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions.
Further details on Pfizer's data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Small for Gestational Age (SGA)
-
PfizerCompletedSmall For Gestational Age (SGA)Spain
-
Société des Produits Nestlé (SPN)CompletedSmall for Gestational Age (SGA) Infants | Appropriate for Gestational Age (AGA) InfantsIndia
-
SandozTerminatedShort Children Born Small for Gestational Age (SGA)Czechia, Germany, Hungary, Poland, Georgia, Romania
-
Changchun GeneScience Pharmaceutical Co., Ltd.RecruitingShort Stature Children Born Small for Gestational Age (SGA)China
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A.S., an affiliate of Merck KGaA, Darmstadt, GermanyCompleted
-
Tel-Aviv Sourasky Medical CenterUnknownSmall for Gestational Age Infants | Appropriate for Gestational Age InfantsIsrael
-
Xiamen Amoytop Biotech Co., Ltd.RecruitingSmall for Gestational AgeChina
-
SandozCompletedSmall for Gestational AgeBelgium, Czechia, Georgia, Hungary, Poland, Romania, Germany
-
PfizerCompletedSmall for Gestational Age
-
Dong-A ST Co., Ltd.CompletedInfant, Small for Gestational AgeKorea, Republic of
Clinical Trials on Somatropin
-
Xiamen Amoytop Biotech Co., Ltd.Peking Union Medical College HospitalCompleted
-
PfizerCompletedPrader-Willi SyndromeJapan
-
Changchun GeneScience Pharmaceutical Co., Ltd.The First Affiliated Hospital with Nanjing Medical University; Tongji Hospital and other collaboratorsActive, not recruiting
-
Novo Nordisk A/SCompletedNoonan Syndrome | Genetic DisorderJapan
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Adult Growth Hormone DeficiencyGermany
-
Novo Nordisk A/SCompletedSmall for Gestational Age | Growth DisorderFrance
-
Novo Nordisk A/SCompletedChronic Kidney Disease | Turner Syndrome | Noonan Syndrome | Chronic Renal Insufficiency | Growth Hormone Disorder | Growth Hormone Deficiency in Children | Adult Growth Hormone Deficiency | Genetic Disorder | Foetal Growth Problem | Small for Gestational AgeIsrael, Saudi Arabia, Spain, Argentina, Russian Federation, Germany, Netherlands, Italy, Belgium, United Kingdom, Slovenia, Ireland, Sweden, Denmark, Hungary, Finland, Norway, France, Czechia, Lithuania, Luxembourg, Serbia, Switzerland
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompleted